SIGN UP
LOG IN
P
PLRX
Pliant Therapeutics, Inc.
1.30
0.05+4.00%After Hours: 1.320 +0.020 +1.54%19:08 06/24 EDT
OPEN/PREV CLOSE1.250/1.250
TODAY RANGE1.240-1.330
VOL570.01K
MARKET CAP79.80M
52 WEEK RANGE1.100-16.10
AVG VOL (3M)993.53K
% TURNOVER0.93%
TURNOVER--
P/E (TTM)-0.3600
% RANGE6.73%
EPS(TTM)-3.6107
P/E(FORWARD)-0.5000
P/B0.3103
BVPS4.189
DIVIDEND--
P/S49.24
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP77.35M
SHARES OUTSTANDING61.39M
NEXT EARNINGS08/05-08/11
FREE FLOAT59.50M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·06/09 21:48
Pliant Therapeutics Approves Key Proposals at Annual Meeting
TipRanks·05/09 15:19
Piper Sandler Keeps Their Buy Rating on Pliant Therapeutics (PLRX)
TipRanks·05/09 13:18
Oppenheimer Sticks to Its Hold Rating for Pliant Therapeutics (PLRX)
Seeking Alpha·05/08 21:58
Pliant Therapeutics GAAP EPS of -$0.92 misses by $0.18
Benzinga·05/05 12:07
12 Health Care Stocks Moving In Monday's Pre-Market Session
Seeking Alpha·05/02 14:27
Pliant Therapeutics to trim about 45% of workforce
Dow Jones·05/01 21:45
Pliant Therapeutics Reduces Workforce as Part of Strategic Realignment
TipRanks·05/01 21:00
Pliant Therapeutics to reduce workforce by 45%
TipRanks·05/01 20:34
Pliant Therapeutics Announces Major Workforce Reduction
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.